1. Home
  2. Stocks
  3. Star Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Strides Pharma Science

    Mid Cap
    ₹1,021.6
    + 32.4 (3.28%)
    • Advice
    • Hold
    27 July, 2024 14:45 BSE: 532531 NSE: STAR ISIN: INE939A01011

    Start SIP in Strides Pharma Science

    Start SIP

    Strides Pharma Science Performance

    Day Range

    • Low 992
    • High 1,032
    ₹ 1,021

    52 Week Range

    • Low 412
    • High 1,032
    ₹ 1,021
    • Open Price997
    • Previous Close989
    • Volume422690

    Strides Pharma Science Share Price

    • Over 1 Month + 7.04%
    • Over 3 Month + 16.53%
    • Over 6 Month + 48.86%
    • Over 1 Year + 131.39%

    Strides Pharma Science Key Statistics

    P/E Ratio -133
    PEG Ratio -2
    Market Cap Cr
    Price to Book Ratio 4.5
    EPS 7.7
    Dividend 0.1
    Relative Strength Index 68.68
    Money Flow Index 73.55
    MACD Signal 13.04
    Average True Range 32.98
    Strides Pharma Science Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 618520540475564
    Operating Expenses Qtr Cr 527454497420444
    Operating Profit Qtr Cr 91664356119
    Depreciation Qtr Cr 2121212123
    Interest Qtr Cr 4744403743
    Tax Qtr Cr -11313
    Net Profit Qtr Cr 5431862
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 2,2261,939
    Operating Expenses Annual Cr 1,8981,756
    Operating Profit Annual in Cr 25598
    Depreciation Cr 8594
    Interest Annual Cr 168139
    Tax Annual Cr 4-69
    Net Profit Annual Cr 655
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -36242
    Cash from Investing Activity Annual Cr -61-183
    Cash from Financing Annual Activity Cr 10811
    Net Cash Flow Annual Cr 1170
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 3,5613,455
    Fixed Assets Annual Cr 650652
    Total Non Current Assets Annual Cr 3,4223,493
    Total Current Assets Annual Cr 2,4162,126
    Total Assets Annual Cr 5,8385,620
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 387383
    ROE Annual % 20
    ROCE Annual % 62
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1510
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 1,0841,038999930986
    Operating Expenses Qtr Cr 854844846763831
    Operating Profit Qtr Cr 230194153167156
    Depreciation Qtr Cr 5051606061
    Interest Qtr Cr 8079797681
    Tax Qtr Cr 1910-7107
    Net Profit Qtr Cr 1850-131-7-10
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 4,0913,779
    Operating Expenses Annual Cr 3,3083,258
    Operating Profit Annual in Cr 743430
    Depreciation Cr 221243
    Interest Annual Cr 314261
    Tax Annual Cr 32-55
    Net Profit Annual Cr -71-203
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 70144
    Cash from Investing Activity Annual Cr -150302
    Cash from Financing Annual Activity Cr -693-214
    Net Cash Flow Annual Cr -143133
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 2,1262,195
    Fixed Assets Annual Cr 1,4981,948
    Total Non Current Assets Annual Cr 2,8713,395
    Total Current Assets Annual Cr 2,9693,243
    Total Assets Annual Cr 5,8406,638
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 225239
    ROE Annual % -3-9
    ROCE Annual % 198
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1914
    Invest in Strides Pharma Science

    Strides Pharma Science Technicals

    EMA & SMA

    Current Price
    ₹1,021.6
    + 32.4 (3.28%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹957.32
    • 50 Day
    • ₹923.65
    • 100 Day
    • ₹867.82
    • 200 Day
    • ₹764.64
    • 20 Day
    • ₹951.57
    • 50 Day
    • ₹919.26
    • 100 Day
    • ₹872.81
    • 200 Day
    • ₹739.15

    Strides Pharma Science Resistance and Support

    PIVOT
    ₹1,015.22
    Resistance
    First Resistance 1,038.38
    Second Resistance 1,055.17
    Third Resistance 1,078.33
    RSI 68.68
    MFI 73.55
    MACD Single Line 13.04
    MACD 19.59
    Support
    First Support 998.43
    Second Support 975.27
    Third Supoort 958.48

    Strides Pharma Science Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 438,215 25,543,552 58.29
    Week 481,152 29,696,714 61.72
    1 Month 270,745 14,652,735 54.12
    6 Month 475,360 21,823,756 45.91

    Strides Pharma Science Result Highlights

    Strides Pharma Science Synopsis

    NSE-Medical-Generic Drugs

    Strides Pharma Scien is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1854.50 Cr. and Equity Capital is Rs. 90.30 Cr. for the Year ended 31/03/2023. Strides Pharma Science Ltd. is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062.
    Market Cap 9,390
    Sales 2,153
    Shares in Float 6.80
    No of funds 199
    Yield 0.15
    Book Value 2.64
    U/D Vol ratio 1.9
    LTDebt / Equity 6
    Alpha 0.25
    Beta 0.83

    Strides Pharma Science Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 25.86%25.88%27.39%27.78%
    Mutual Funds 10.5%10.57%13.09%13.67%
    Insurance Companies 6.16%5.77%4.46%4.54%
    Foreign Portfolio Investors 26.71%24.57%19.45%17.25%
    Financial Institutions/ Banks 0.01%0.01%0.01%0.01%
    Individual Investors 20.87%21.19%22.64%23.39%
    Others 9.89%12.01%12.96%13.36%

    Strides Pharma Science Management

    Name Designation
    Mr. Arun Kumar Exe.Chairman & Mng.Director
    Mr. Badree Komandur Executive Director & Group CFO
    Dr. Kausalya Santhanam Independent Director
    Mr. Bharat D Shah Independent Director
    Mr. Homi Rustam Khusrokhan Independent Director
    Mr. S Sridhar Independent Director

    Strides Pharma Science Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Strides Pharma Science Corporate Action

    Date Purpose Remarks
    2024-07-29 Quarterly Results
    2024-05-22 Audited Results & Final Dividend
    2024-01-30 Quarterly Results
    2023-10-30 Quarterly Results
    2023-09-25 Scheme of Arrangement
    Date Purpose Remarks
    2023-08-04 FINAL Rs.1.50 per share(15%)Final Dividend
    2021-08-06 FINAL Rs.2.50 per share(25%)Final Dividend

    Strides Pharma Science MF Shareholding

    Name Amount(cr)
    Quant Small Cap Fund Growth 22,967
    Aditya Birla Sun Life Flexi Cap Fund Growth 21,896
    Quant Active Fund Growth 10,758
    Aditya Birla Sun Life Pure Value Fund Growth 6,226
    Quant Value Fund Regular Growth 1,915

    Strides Pharma Science FAQs

    What is Share Price of Strides Pharma Science ?

    Strides Pharma Science share price is ₹1,021 As on 27 July, 2024 | 14:31

    What is the Market Cap of Strides Pharma Science ?

    The Market Cap of Strides Pharma Science is ₹9390.2 Cr As on 27 July, 2024 | 14:31

    What is the P/E ratio of Strides Pharma Science ?

    The P/E ratio of Strides Pharma Science is -133 As on 27 July, 2024 | 14:31

    What is the PB ratio of Strides Pharma Science ?

    The PB ratio of Strides Pharma Science is 4.5 As on 27 July, 2024 | 14:31

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.